Procalcitonin News and Research

RSS

Sphingotec's new biomarker bio-ADM identifies ICU patients who need immediate organ support

Diagnostics company SphingoTec GmbH today announced a publication in Critical Care1 with data on 2,000 ICU patients demonstrating that sphingotec's proprietary biomarker bio-ADM (Bioactive Adrenomedullin) not only identifies high-risk patients for septic shock at admission but also identifies patients in the general ICU patient population who require immediate life-saving therapeutic intervention.

23 Dec 2019

Sphingotec's penKid is a reliable marker for detection and monitoring of acute kidney injury

Diagnostics company SphingoTec GmbH today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC Emergency Medicine.

21 Dec 2019

Novel sensor could accelerate diagnosis of sepsis

A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.

24 Jul 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

New protocol can help identify febrile infants at low risk for serious bacterial infections

A national research team led by UC Davis Health clinicians and researchers from the University of Michigan, Nationwide Children's Hospital and Columbia University, has derived and validated a new protocol for emergency departments that can determine which infant patients with fevers, age 60 days or younger, are at low risk of significant bacterial infections.

18 Feb 2019

New protocol could help physicians to rule out bacterial infections in infants

A new protocol could help emergency room physicians to rule out life-threatening bacterial infections among infants up to 2 months of age who have fevers, potentially eliminating the need for spinal taps, unnecessary antibiotic treatments or expensive hospital stays.

18 Feb 2019

Biomarker blood test does not appear to curb antibiotic overuse, shows new study

Overall antibiotic use was not curbed by giving physicians the results of biomarker tests in patients with suspected lower respiratory tract infections, according to findings from the Procalcitonin Antibiotic Consensus Trial.

21 May 2018

Scientists develop rapid test for early diagnosis of heart attack and to identify sepsis

NUST MISIS scientists have developed a new type of membrane test strip for the quantitative immunochromatographic rapid-test that will be able to accurately and quickly make an early diagnosis of an acute myocardial infarction through the presence of disease markers in blood, as well as to identify various things such as sepsis, a pregnancy's duration, and viral & bacterial infections.

29 Jan 2018

EKF’s PCT LiquiColor assay receives FDA clearance and validation for use on Beckman AU analyzers

EKF, announces that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared with Beckman AU 480, 680 and 5800 clinical chemistry analyzers.

From EKF Diagnostics 15 Nov 2017

Endogenous infection marker can help guide antibiotic use

The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers from the University of Basel and other colleagues report in the journal The Lancet Infectious Diseases.

16 Oct 2017

New study aims to tackle antibiotic resistance in sepsis patients

University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.

28 Jun 2017

EKF Diagnostics expands the distribution of its Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC regions

EKF, announces that it is expanding the distribution of its Procalcitonin LiquiColor Test into Eastern Europe, Middle East and APAC regions.

From EKF Diagnostics 3 May 2017

PCT screening could be promising tool to help shorten hospital stays, reduce costs for sepsis patients

Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals.

10 Jan 2017

Good blood microcirculation linked to longevity

Human longevity has been previously linked by researchers to genetic factors, calorie restriction, and certain life-style factors such as physical activity or the Mediterranean diet.

6 Sep 2016

UK Export Award winner BBI Solutions to attend 2016 AACC

BBI Solutions, recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month.

30 Jul 2016

Researchers propose new method for diagnosis of bacterial infection in preterm infants

A research group led by Kobe University Professor MORIOKA Ichiro (Graduate School of Medicine, Department of Pediatrics), Associate Professor OSAWA Kayo (Graduate School of Health Sciences, Department of Biophysics), and Clinical Technologist SATO Itsuko (Kobe University Hospital, Department of Clinical Laboratory) is proposing a new criterion for diagnosis of bacterial infection in preterm infants.

2 Apr 2016

FDA clearance expands clinical claims of Thermo Scientific B•R•A•H•M•S PCT biomarker for sepsis risk assessment

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has received clearance from the U.S. Food and Drug Administration that expands the clinical claims of the Thermo Scientific B·R·A·H·M·S PCT biomarker assay for sepsis risk assessment.

From Thermo Fisher Scientific Inc. 2 Mar 2016